Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.92M | 6.07M | 5.29M | 4.89M | 4.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.92M | 6.07M | 5.29M | 4.89M | 4.91M |
| Cost of Revenue | 955.00K | 1.08M | 1.06M | 977.00K | 936.00K |
| Gross Profit | 3.97M | 4.99M | 4.23M | 3.91M | 3.97M |
| SG&A Expenses | 1.29M | 1.69M | 1.26M | 1.22M | 1.03M |
| Depreciation & Amortization | 273.00K | 269.00K | 342.00K | 343.00K | 341.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.55M | 3.05M | 2.76M | 2.54M | 2.34M |
| Operating Income | 2.37M | 3.02M | 2.53M | 2.35M | 2.57M |
| Income Before Tax | 3.68M | 3.12M | 3.17M | 2.71M | 2.93M |
| Income Tax Expenses | -3.97M | -3.91M | 99.00K | 82.00K | -16.75M |
| Earnings from Continuing Operations | 7.66M | 7.03M | 3.07M | 2.63M | 19.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.66M | 7.03M | 3.07M | 2.63M | 19.68M |
| EBIT | 2.37M | 3.02M | 2.53M | 2.35M | 2.57M |
| EBITDA | 2.55M | 3.29M | 2.87M | 2.69M | 2.83M |
| EPS Basic | 0.32 | 0.28 | 0.12 | 0.10 | 0.78 |
| Normalized Basic EPS | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 |
| EPS Diluted | 0.30 | 0.27 | 0.12 | 0.10 | 0.77 |
| Normalized Diluted EPS | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 |
| Average Basic Shares Outstanding | 24.26M | 25.31M | 25.34M | 25.12M | 25.12M |
| Average Diluted Shares Outstanding | 24.78M | 25.70M | 25.72M | 25.55M | 25.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
